Composition:
Contains 1mg of rapamycin per tablet and the excipients microcrystalline cellulose ,polyvinlpyrrolidone,Isopropyl alcohol ,magnesium stearate,poloxamer 188,dl-alpha,tocopherol,hydroxypropl methylcellulose ,polyethylene glycol , tartrazine ,ethylene chloride.
Classification:
RapaPro is an MTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection and patients at low to moderate immunologic risk and lymphangioleiomyomatosis.
Contraindications:
Hypersensitivity to RapaPro. Avoid concomitants use with strong CYP3A4/P-gp inducers, or strong CTP3A4/P-gp inhibitors that can decrease or increase rapamycin concentrations.












